SCHEMBL4929067

SCHEMBL4929067

Cn1cc(C[C@@H](N)C(=O)NO)c2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.52
▸ MAPT P10636 2/20 0.52
▸ RECQL P46063 1/20 0.52
▸ MMP9 P14780 1/20 0.51
▸ MMP8 P22894 1/20 0.51
▸ KDM4E B2RXH2 3/20 0.50
▸ GPR84 Q9NQS5 1/20 0.50
▸ HPGD P15428 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ CA2 P00918 1/20 0.49
▸ HTR2A P28223 1/20 0.49
▸ LMNA P02545 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ HDAC6 Q9UBN7 3/20 0.46
▸ HDAC8 Q9BY41 2/20 0.46
▸ HDAC3 O15379 2/20 0.46
▸ HDAC1 Q13547 2/20 0.46
▸ PTPN5 P54829 1/20 0.45
▸ HDAC4 P56524 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4929082 1.00 ALDH1A1 (0.52) ALDH1A1MAPTRECQLMMP9MMP8
SCHEMBL4926389 0.86 ICMT (0.50) ALDH1A1MAPTRECQLKDM4EHSD17B10
SCHEMBL4933922 0.86 ICMT (0.50) ALDH1A1MAPTRECQLKDM4EHSD17B10
SCHEMBL4926380 0.86 ICMT (0.50) ALDH1A1MAPTRECQLKDM4EHSD17B10
SCHEMBL4930600 0.85 ALDH1A1 (0.51) ALDH1A1MAPTRECQLLMNAMEN1
SCHEMBL4930609 0.85 ALDH1A1 (0.51) ALDH1A1MAPTRECQLLMNAMEN1
SCHEMBL4932173 0.85 ALDH1A1 (0.51) ALDH1A1MAPTRECQLLMNAMEN1
SCHEMBL18407282 0.85 ALDH1A1 (0.51) ALDH1A1MAPTRECQLKDM4EGPR84
SCHEMBL24445574 0.85 SCN9A (0.57) ALDH1A1MAPTRECQLKDM4EGPR84
SCHEMBL17306338 0.85 ALDH1A1 (0.56) ALDH1A1MAPTRECQLKDM4EGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative KUREHA CORPORATION (JP) 2008-06-05 — — US disclosed
EP-1707560-A1 HYDROXAMIC ACID DERIVATIVE AND AGE GENERATION INHIBITOR CONTAINING THE DERIVATIVE Kureha Corporation (JP) 2006-10-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative HDAC5, HDAC1, HDAC9 ALDH1A1 1829/4885MAPT 2275/4885RECQL 3225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback